Ramez N. Eskander, MD
Gynecologic Oncologist
University of California at Irvine Medical Center
101 The City Drive, South
Building 56, Room 260
Orange,
CA
USA
92868
Biographical Sketch: 2012: Exxcellence Foundation, Philip J DiSaia Research grant award recipient 2012: Queen of Hearts Research Award Recipient Eskander, R N, Sakai T, Guo Y, Randall L, Hoang B, Zi X. Flavokawain B, a novel chalcone, exhibits robust apoptotic effects and indices G2/M arrest of a uterine leiomyosarcoma cell line; Journal of Obstetrics and Gynecology Research 2012; PMID: 22540374. My laboratory and clinical research projects have resulted in 10 peer-reviewed publications in less than 24 months"
Papers:
5
Correlation between surgeon's assessment of residual disease and findings on postoperative pre-treatment computed tomography scan in women with advanced stage ovarian cancer reported to have undergone optimal cytoreduction: an NRG Oncology/GOG study
57
Impact of treatment-induced neutropenia and thrombocytopenia on survival in patients with advanced ovarian cancer treated with chemotherapy plus bevacizumab: an NRG Oncology/Gynecologic Oncology Group ancillary data study
62
Complete responses in the irradiated field following treatment with chemotherapy with and without bevacizumab in advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study
GOFRN announcment